SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.
  • 2
    Warren GW, Kasza KA, Reid ME, Cummings KM, Marshall JR. Smoking at diagnosis and survival in cancer patients. Int J Cancer. 2013;132:401-410.
  • 3
    Dal Maso L, Zucchetto A, Talamini R, et al. Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer. 2008;123:2188-2194.
  • 4
    Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E. Smoking and prostate cancer survival and recurrence. JAMA. 2011;305:2548-2555.
  • 5
    Modesitt SC, Huang B, Shelton BJ, Wyatt S. Endometrial cancer in Kentucky: the impact of age, smoking status, and rural residence. Gynecol Oncol. 2006;103:300-306.
  • 6
    Duffy SA, Taylor JM, Terrell JE, et al. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer. 2008;113:750-757.
  • 7
    van den Belt-Dusebout AW, de Wit R, Gietema JA, et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol. 2007;25:4370-4378.
  • 8
    Gajdos C, Hawn MT, Campagna EJ, Henderson WG, Singh JA, Houston T. Adverse effects of smoking on postoperative outcomes in cancer patients. Ann Surg Oncol. 2012;19:1430-1438.
  • 9
    Mason DP, Subramanian S, Nowicki ER, et al. Impact of smoking cessation before resection of lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery database study. Ann Thorac Surg. 2009;88:362-370.
  • 10
    Bittner N, Merrick GS, Galbreath RW, et al. Primary causes of death after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2008;72:433-440.
  • 11
    American Society of Clinical Oncology (ASCO). ASCO policy statement update: tobacco control-reducing cancer incidence and saving lives. J Clin Oncol. 2003;15:2777-2786.
  • 12
    Viswanath K, Herbst RS, Land SR, Leischow SJ, Shields PG. Tobacco and cancer: an American Association for Cancer Res. policy statement. Cancer Res. 2010;70:3419-3430.
  • 13
    National Comprehensive Cancer Network (NCCN). Patient and Caregiver Resources: Quitting Smoking for Cancer Survivors. Available at: http://www.nccn.org/patients/resources/survivorship/smoking.aspx. Accessed October 10, 2013.
  • 14
    Joseph AM, Knapp JM, Nichol KL, Pirie PL. Determinants of compliance with a national smoke-free hospital standard. JAMA. 1995;274:491-494.
  • 15
    Tobacco cessation and quality cancer care. J Oncol Pract. 2009;5:2-5.
  • 16
    Morgan G, Schnoll RA, Alfano CM, et al. National Cancer Institute conference on treating tobacco dependence at cancer centers. J Oncol Pract. 2011;7:178-182.
  • 17
    Toll BA, Brandon T, Gritz ET, Land SR, Warren GW, Herbst RA. Assessing and stopping cancer patients' tobacco use: an American Association for Cancer research policy statement. Clin Cancer Res. 2013;19:1941-1948.
  • 18
    Oncology Nursing Society. Oncology Nursing Society Position on Nursing Leadership in Global and Domestic Tobacco Control. Available at: http://www.ons.org/Publications/Positions/Tobacco/, Accessed October 10, 2013.
  • 19
    Mazza R, Lina M, Invernizzi G, et al. The gap between tobacco treatment guidelines, health service organization, and clinical practice in comprehensive cancer centres [serial online]. J Oncol 2011:145617, 2011.
  • 20
    Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis [serial online]. BMJ. 2010;340:b5569.
  • 21
    Land SR. Methodologic barriers to addressing critical questions about tobacco and cancer prognosis. J Clin Oncol. 2012;30:2030-2032.
  • 22
    Peters EN, Torres E, Toll BA, et al. tobacco assessment in actively accruing National Cancer Institute (NCI) Cooperative Group clinical trials. J Clin Oncol. 2012;30:2869-2875.
  • 23
    Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2008.
  • 24
    Campbell HS, Ossip-Klein D, Bailey L, Saul J; North American Quitline Consortium. Minimal dataset for quitlines: a best practice. Tob Control. 2007;16(suppl 1):i16-i20.
  • 25
    Gritz ER, Dresler CM, Sarna L. Smoking, the missing drug interaction in clinical trials. Cancer Epidemiol Biomarkers Prev. 2005;14:2287-2293.
  • 26
    Cooley ME, Emmons KM, Haddad R, et al. Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancer. Cancer. 2011;117:2961-2969.
  • 27
    Ostroff JS, Jacobsen PB, Moadel AB, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995;75:569-576.
  • 28
    Schnoll RA, Rothman RL, Newman H, et al. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients. Psychooncology. 2004;13:346-358.
  • 29
    Cooley ME, Sarna L, Kotlerman J, et al. Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent. Lung Cancer. 2009;66:218-225.
  • 30
    Warren GW, Marshall JR, Cummings KM, et al. Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients. J Thorac Oncol. 2013;8:543-548.
  • 31
    Hald J, Overgaard J, Grau C. Evaluation of objective measures of smoking status—a prospective clinical study in a group of head and neck cancer patients treated with radiotherapy. Acta Oncol. 2003;42:154-159.
  • 32
    Warren GW, Arnold SM, Valentino JP, et al. Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population. Radiother Oncol. 2012;103:45-48.
  • 33
    Khuri FR, Kim ES, Lee J, et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev. 2001;10:823-829.
  • 34
    Schnoll RA, Rothman RL, Lerman C, et al. Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollment. Head Neck. 2004;26:278-286.
  • 35
    Vidrine JI, Shete S, Cao Y, et al. Ask-Advise-Connect: a new approach to smoking treatment delivery in health care settings. JAMA Intern Med. 2013;173:458-464.